Bharat Rasayan Limited (BHARATRAS) AI Stock Analysis

• Market Cap: ₹46.05B
• Dividend Yield: 0.01%
• Average Volume (3M): 149.00
• Price to Earnings (P/E): 33.5
• Beta (1Y): 0.33
• Revenue Growth: 16.60%
• EPS Growth: 4.50%
• Country: IN
• Employees: 816
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 95.44
• Shares Outstanding: 4,155,268
• 10 Day Avg. Volume: 116
• 30 Day Avg. Volume: 149
• PEG Ratio: 0.64
• Price to Book (P/B): 3.78
• Price to Sales (P/S): 3.64
• P/FCF Ratio: 32.32
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: ₹12,513.00 ▲(13.80% Upside)

Bharat Rasayan's strong financial performance is the primary driver of its stock score, supported by robust revenue and profit growth, low leverage, and effective cash flow management. However, technical indicators suggest the stock may be overbought, and valuation metrics indicate potential overvaluation, which tempers the overall score.

Bharat Rasayan Limited Business Overview & Revenue Model

Company Description

Bharat Rasayan Limited (BHARATRAS) is a prominent Indian company engaged in the manufacturing and distribution of agrochemicals and pesticides. Established in 1985, the company focuses on providing high-quality crop protection solutions to enhance agricultural productivity. BHARATRAS operates primarily in the agricultural sector, offering a diverse range of products including insecticides, herbicides, and fungicides, catering to the needs of farmers and agricultural enterprises across India and internationally.

How the Company Makes Money

Bharat Rasayan Limited generates revenue primarily through the sale of its agrochemical products, which are crucial for pest control and crop protection in the agricultural sector. The company's revenue model is driven by the production and distribution of a wide variety of pesticides and related chemicals that are essential for enhancing crop yields. Key revenue streams include direct sales to farmers, partnerships with agricultural distributors, and collaborations with international agrochemical companies for product development and distribution. Additionally, the company benefits from economies of scale in manufacturing, enabling it to maintain competitive pricing while maximizing profit margins. The growing demand for sustainable agricultural practices and the increasing awareness of crop protection products further contribute to its earnings.

Bharat Rasayan Limited Financial Statement Overview

Summary

Bharat Rasayan demonstrates strong financial health with impressive revenue and profit growth, low leverage, and robust cash flow generation. The company is well-positioned in the agricultural inputs industry, with efficient operations and sound financial management.

Income Statement

Bharat Rasayan has shown strong revenue growth, with a 12.3% increase from 2024 to 2025. Gross profit margin has remained robust at 33.8% in 2025. The net profit margin improved significantly to 12.0% in 2025, indicating effective cost management. Both EBIT and EBITDA margins have improved, suggesting enhanced operational efficiency.

Balance Sheet

The company maintains a healthy financial position with a low debt-to-equity ratio of 0.08 in 2025, signaling minimal leverage risk. Return on Equity is strong at 12.5%, reflecting effective use of equity. The equity ratio is impressive at 80.3%, indicating financial stability and a solid asset base.

Cash Flow

Operating cash flow has improved significantly, aligning well with net income, resulting in a healthy operating cash flow to net income ratio of 1.19. Free cash flow saw remarkable growth, indicating strong cash generation capabilities. Free cash flow to net income ratio stands at 0.97, showing effective cash management.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	12.68B	11.73B	10.45B	12.34B	12.95B	10.80B
Gross Profit	4.34B	3.96B	3.24B	3.95B	3.69B	3.30B
EBITDA	2.18B	2.01B	1.38B	2.06B	2.66B	2.45B
Net Income	1.37B	1.41B	955.10M	1.25B	1.76B	1.64B
Balance Sheet
Total Assets	0.00	14.08B	11.97B	10.74B	10.86B	9.08B
Cash, Cash Equivalents and Short-Term Investments	2.86B	2.86B	1.41B	485.96M	66.88M	1.39B
Total Debt	0.00	852.19M	804.74M	279.37M	1.74B	584.46M
Total Liabilities	-11.30B	2.78B	2.10B	1.80B	3.16B	1.81B
Stockholders Equity	11.30B	11.30B	9.88B	8.93B	7.70B	7.27B
Cash Flow
Free Cash Flow	0.00	1.32B	140.26M	1.90B	-1.21B	1.40B
Operating Cash Flow	0.00	1.68B	410.76M	2.13B	-654.55M	1.70B
Investing Cash Flow	0.00	-1.57B	-897.00M	-605.49M	511.36M	-1.53B
Financing Cash Flow	0.00	41.22M	489.57M	-1.52B	-247.85M	-397.29M

Bharat Rasayan Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10995.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BHARATRAS, the sentiment is Positive. The current price of 10995.8 is above the 20-day moving average (MA) of 10486.81, above the 50-day MA of 10227.15, and above the 200-day MA of 10207.94, indicating a bullish trend. The MACD of 250.23 indicates Negative momentum. The RSI at 58.12 is Neutral, neither overbought nor oversold. The STOCH value of 33.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BHARATRAS.

Bharat Rasayan Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BHARATRAS	65 Neutral	₹46.05B	33.50	―	0.01%	16.60%	4.50%
INSECTICID	64 Neutral	₹20.04B	13.38	―	0.73%	2.61%	24.65%
RCF	62 Neutral	₹84.27B	29.46	―	0.89%	-8.23%	69.99%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
RALLIS	56 Neutral	₹50.89B	28.92	―	1.01%	0.91%	18.12%
NFL	49 Neutral	₹45.48B	29.68	―	1.68%	-22.78%	-41.69%
NACLIND	46 Neutral	₹40.30B	-56.71	―	―	-13.44%	-127.94%